L.acidophilus participates in intestinal inflammation induced by PM2.5 through affecting the Treg/Th17 balance

Jie Xu1, Jing Wang2, Yuefeng He1

  • 1Yunnan Provincial Key Laboratory of Public Health and Biosafety & School of Public Health, Kunming Medical University, Kunming 650500, China.

Insights

Particulate matter (PM2.5) exposure causes intestinal inflammation by disrupting the Treg/Th17 balance and reducing Lactobacillus acidophilus. Supplementing L. acidophilus can protect against this inflammation.

Area of Science:

  • Environmental Health
  • Gastroenterology
  • Immunology

Background:

  • Particulate matter (PM2.5) is linked to multi-organ damage, with growing interest in its gastrointestinal effects.
  • The intestine, a major immune organ with high microbial content, is susceptible to PM2.5-induced inflammation.

Purpose of the Study:

  • To investigate the mechanisms of PM2.5-induced intestinal inflammation.
  • To explore the role of the gut immune system and microbiota in PM2.5 exposure.

Main Methods:

  • Established four PM2.5 exposure models in rodents.
  • Conducted regulatory T cell (Treg) transplantation experiments.
  • Utilized 16S rDNA third-generation sequencing for microbial analysis.
  • Performed mechanistic studies on Lactobacillus acidophilus (L. acidophilus) and Treg/Th17 balance.

Main Results:

  • PM2.5 exposure induced intestinal inflammation by creating an imbalance between regulatory T cells (Tregs) and T helper 17 cells (Th17).
  • PM2.5 significantly decreased the abundance of L. acidophilus in the gut.
  • L. acidophilus was confirmed to be involved in the Treg/Th17 imbalance.
  • Supplementation with L. acidophilus alleviated PM2.5-induced intestinal inflammation by restoring Treg/Th17 balance.

Conclusions:

  • PM2.5 exposure disrupts the intestinal immune homeostasis, specifically the Treg/Th17 balance, contributing to inflammation.
  • L. acidophilus plays a crucial role in mitigating PM2.5-induced gut inflammation.
  • L. acidophilus supplementation presents a potential therapeutic strategy against PM2.5-related intestinal damage.